Second cadaver kidney transplants: improved graft survival in secondary kidney transplants using cyclosporin A
- PMID: 6361283
- PMCID: PMC2981093
- DOI: 10.1016/s0022-5347(17)50172-x
Second cadaver kidney transplants: improved graft survival in secondary kidney transplants using cyclosporin A
Abstract
A total of 42 patients who had failed prior renal transplantation underwent repeat cadaveric transplantation using cyclosporin A and low dose steroid immunosuppression. Patient survival at 1 year was 100 per cent. Over-all graft survival was 83 per cent at 1 year, which was significantly better than had been obtainable previously in this high risk group. Repeat cadaver transplantation with cyclosporin A is safe and offers those who have failed previous transplantation an opportunity for existence free of dialysis.
Figures
References
-
- Calne RY, Rolles K, White DJG, Thiru S, Evans DB, McMaster P, Dunn DC, Craddock GN, Henderson RG, Aziz S, Lewis P. Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet. 1979;2:1033. - PubMed
-
- Ferguson RM, Rynasiewicz JJ, Sutherland DER, Simmons RL, Najarian JS. Cyclosporin A in renal transplantation: a prospective randomized trial. Surgery. 1982;92:175. - PubMed
-
- Gifford RRM, Sr, Sutherland DER, Fryd DS, Simmons RL, Najarian JS. Duration of first renal allograft survival as indicator of second allograft outcome. Surgery. 1980;88:611. - PubMed
-
- Opelz G, Terasaki PI. Absence of immunization effect in human-kidney retransplantation. New Engl J Med. 1978;299:369. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical